Publications

Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T.

Authors: EM Serrao, DA Kessler, B Carmo, L Beer, KM Brindle, G Buonincontri, FA Gall...

E-pub date: 16 Oct 2020

Journal name: Sci Rep

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Authors: A Talhouk, J George, C Wang, T Budden, TZ Tan, DS Chiu, S Kommoss, HS Leong...

E-pub date: 15 Oct 2020

Journal name: Clin Cancer Res

Robustness to misalignment of low-cost, compact quantitative phase imaging architectures.

Authors: CRM Fitzpatrick, A Wilson, TW Sawyer, PJ Christopher, TD Wilkinson, SE Bohn...

E-pub date: 15 Oct 2020

Journal name: OSA Contin

Advances and Challenges in Pediatric and Childhood Cancers.

Authors: C Hawkins, S Pfister, DTW Jones, NN Shah, RJ Gilbertson, EA Sweet-Cordero, ...

E-pub date: 12 Oct 2020

Journal name: Cancer Cell

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer.

Authors: S Ros, AJ Wright, P D'Santos, D-E Hu, RL Hesketh, Y Lubling, D Georgopoulou...

E-pub date: 12 Oct 2020

Journal name: Cancer Cell

Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.

Authors: V Gómez, TR Eykyn, R Mustapha, F Flores-Borja, V Male, PR Barber, A Patsia...

E-pub date: 6 Oct 2020

Journal name: Sci Signal

Trajectory and uniqueness of mutational signatures in yeast mutators.

Authors: S Loeillet, M Herzog, F Puddu, P Legoix, S Baulande, SP Jackson, AG Nicolas

E-pub date: 6 Oct 2020

Journal name: Proc Natl Acad Sci U S A

Somatic chromosomal number alterations affecting driver genes inform in-vitro and clinical drug response in high-grade serous ovarian cancer

Authors: FC Martins, D-L Couturier, ID Santiago, CM Sauer, M Vias, M Angelova, D San...

E-pub date: 4 Oct 2020

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T.

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Robustness to misalignment of low-cost, compact quantitative phase imaging architectures.

Advances and Challenges in Pediatric and Childhood Cancers.

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer.

Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.

Trajectory and uniqueness of mutational signatures in yeast mutators.

Somatic chromosomal number alterations affecting driver genes inform in-vitro and clinical drug response in high-grade serous ovarian cancer

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T.

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Robustness to misalignment of low-cost, compact quantitative phase imaging architectures.

Advances and Challenges in Pediatric and Childhood Cancers.

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer.

Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.

Trajectory and uniqueness of mutational signatures in yeast mutators.

Somatic chromosomal number alterations affecting driver genes inform in-vitro and clinical drug response in high-grade serous ovarian cancer